Safety and efficacy of autologous stem cell transplantation in dialysis-dependent myeloma patients—The DIADEM study from the chronic malignancies working party of the EBMT

The role of high-dose chemotherapy followed by autologous stem cell transplantation (ASCT) in the treatment of myeloma (MM) patients with severe and/or dialysis-dependent renal impairment remains uncertain. We report on the outcomes of 110 patients (median age 57 years) who had become dialysis-depen...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Bone marrow transplantation (Basingstoke) 2023-04, Vol.58 (4), p.424-429
Hauptverfasser:	Waszczuk-Gajda, Anna, Gras, Luuk, de Wreede, Liesbeth C., Sirait, Tiarlan, Illes, Arpad, Ozkurt, Zubeyde Nur, Snowden, John A., Arat, Mutlu, Bulabois, Claude Eric, Niederland, Judith, Sever, Matjaz, Paneesha, Shankara, Potter, Victoria, Gadisseur, Alain, Chalopin, Thomas, Van Gorkom, Gwendolyn, López, Joaquin Martínez, Kerre, Tessa, Drozd-Sokolowska, Joanna, Raj, Kavita, Hayden, Patrick J., Beksac, Meral, Yakoub-Agha, Ibrahim, McLornan, Donal P., Schönland, Stefan
Format:	Artikel
Sprache:	eng
Schlagworte:	692/699/1541/1990/804 692/700/565/2319 Age Antineoplastic Combined Chemotherapy Protocols - therapeutic use Autografts Bortezomib Bortezomib - therapeutic use Cell Biology Chemotherapy Dialysis Dosage Hematology Hematopoietic Stem Cell Transplantation Hemodialysis Humans Internal Medicine Life Sciences Malignancy Medicine Medicine & Public Health Melphalan Middle Aged Multiple myeloma Multiple Myeloma - drug therapy Myeloma Public Health Renal Dialysis Renal function Retrospective Studies Stem Cell Transplantation Stem Cells Transplantation Transplantation, Autologous Treatment Outcome
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!